Skip to Main Content

Paper Details

A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation.
Clin Cancer Res
15
2021
Author NameAffiliation
Martijn P LolkemaErasmus MC Cancer Institute
  • 1 - 1

Datasets

Release 1.2